Company Filing History:
Years Active: 2003
Title: Inventor Spotlight: Samuel D. Bernal
Introduction
Samuel D. Bernal, based in Woodland Hills, California, is an innovative inventor focused on the realm of cancer detection and treatment. With a unique approach towards fighting cancer, Bernal has made significant strides in the medical field with his patented invention aimed at targeting epithelial cancer cells.
Latest Patents
Bernal holds a patent for a method designed to detect and kill epithelial cancer cells. This diagnostic method involves selectively marking the mitochondria of cancerous epithelial cells by administering a cationic supravital mitochondrial marking agent to the epithelium. The process allows for the precise killing of cancerous cells while preserving normal cells. Additionally, the killing agent can include a reaction product from the marking agent and a cancer chemotherapeutic drug, enhancing the treatment efficacy.
Career Highlights
Samuel D. Bernal has demonstrated his commitment to cancer research and innovation through his work at Zila, Inc., where he has contributed to the development of groundbreaking diagnostic and treatment methods. His dedication to improving cancer care is evident through his invention and the impact it could have on patients diagnosed with malignant conditions.
Collaborations
Throughout his career, Bernal has collaborated with prominent colleagues such as Douglas D. Burkett and Ralph E. Green. These collaborations highlight the importance of teamwork in the pursuit of medical advancements and the significant role that diverse expertise plays in innovation.
Conclusion
Samuel D. Bernal is a testament to the power of innovation in medicine, particularly in the fight against cancer. His patented method for detecting and killing epithelial cancer cells represents a crucial step forward in improving diagnostic techniques and treatment options for patients. Through his work at Zila, Inc. and his collaborations with valued coworkers, Bernal continues to pave the way for future advancements in cancer therapy.